Elias K Haddad

21PUBLICATIONS
89CO-AUTHORS
VenereologyInnate immunityMedical virologyPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 05, 2026
Virus reactivation in acute and long COVID-19.

|Jun 05, 2026
Early immune events during SARS-CoV-2 infection impact memory T and B cell responses.

|Mar 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Abigail Glascock, Cole Maguire, Hoang Van Phan

|Jan 03, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.

Naresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena

|Jun 30, 2025
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.

Charles Langelier, Abigail Glascock, Cole Maguire

|May 15, 2024
The molecular immune modulator adenosine deaminase-1 enhances HIV specific humoral and cellular responses to a native-like HIV envelope trimer DNA vaccine.

Michele A Kutzler, Gina Cusimano, David Joyner

Pageof 4

Frequent Collaborators

9 joint publications

Matthew C Altman

9 joint publications

Holden T Maecker

9 joint publications

Charles Cairns

8 joint publications

Florian Krammer